Výsledky vyhledávání

Dissertation/ Thesis

Autor: Mindy Hsiao, 蕭筱筠

Externí odkaz: http://ndltd.ncl.edu.tw/handle/30861472195586107615

First Report of Severe Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome Treated With Atezolizumab: Literature Review

Autor: Bassam Yaghmour, Tarek Khedro, George Yaghmour, Mindy Hsiao, Sergei Tatishchev, Casey O'Connell

Publikováno v: World Journal of Oncology

Checkpoint inhibitors have become a widely used and available immunotherapy option for treating a variety of malignancies, including hematological malignancies. Patients receiving these therapies may go on to receive a curative allogeneic hematopoiet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f6dde0cdb26286a1db2a792855017b7
https://doi.org/10.14740/wjon1263

Zobrazit plný text záznamu

Updated Outcomes during the Pandemic: Relationship between CD34 and CD3 Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation Using Post Transplant Cytoxan: A Single Center Experience

Autor: George Yaghmour, Karrune Woan, Jack Rodman, Abdullah Ladha, Mindy Hsiao, Preet M. Chaudhary, Anastasia Martynova, Krithika Chennapan, Eric Tam

Publikováno v: Transplantation and Cellular Therapy. 28:S228-S229

Background: Haploidentical hematopoietic cell transplantation (haplo-HCT) has emerged as a popular alternative to traditional HLA-matched hematopoietic cell transplant. The major advancement of haplo-HCT has increased donor availability to many patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f57f0042e0271dba644dedfc77695d5
https://doi.org/10.1016/s2666-6367(22)00449-3

Zobrazit plný text záznamu

Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation

Autor: Jeremy Chang, Mindy Hsiao, Mojtaba Akhtari, Emily Blodget

Publikováno v: Journal of Blood Medicine. 10:135-143

Background: While haploidentical transplantation has led to the near-universal availability of donors, several challenges for this form of transplant still exist. This study sought to investigate the rates of infection-related mortality and other com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3cf9c212432cbd256b817607befeadc1
https://doi.org/10.2147/jbm.s201073

Zobrazit plný text záznamu

Plný text ve formátu HTML

Real-World Experience Using Letermovir for CMV Prophylaxis in High-Risk Allogeneic Hematopoietic Stem Cell Patients in the Setting of Using T-Cell Depletion As GVHD Prophylaxis and the Impact on CMV Reactivation, 1-Year Overall Survival, and 1-Year GVHD-Free-Relapse-Free Survival

Autor: George Yaghmour, Sami Dwabe, Mindy Hsiao

Publikováno v: Transplantation and Cellular Therapy. 27:S349-S350

Background: Cytomegalovirus (CMV) is a major cause of morbidity in allogeneic hematopoietic stem cell transplant (HSCT) patients. Marty et al. 2017 showed that letermovir is effective in preventing CMV reactivation in high-risk HSCT patients, though

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45f491487dd694a276329c62e264f8a4
https://doi.org/10.1016/s2666-6367(21)00449-8

Zobrazit plný text záznamu

Evaluating GVHD Outcomes Using Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil As GVHD Prophylaxis Compared with Methotrexate/Tacrolimus in Matched-Related and Matched-Unrelated Hematopoietic Stem Cell Transplant in Relation to the Haplo-Identical Setting: A Single Center Experience

Autor: Preet M. Chaudhary, Mindy Hsiao, George Yaghmour

Publikováno v: Transplantation and Cellular Therapy. 27:S289-S290

Background: The use of post-transplant cyclophosphamide (PTCy)/tacrolimus/mycophenolate mofetil (MMF) for GVHD prophylaxis has improved outcomes in haploidentical hematopoietic cell transplantation (haplo-HCT). PTCy is now being evaluated in matched-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e42a1b53a8ace3597e0876ed29331a2d
https://doi.org/10.1016/s2666-6367(21)00369-9

Zobrazit plný text záznamu

Investigating the Relationship between CD34+and CD3+ Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation Using Post Transplant Cytoxan: A Single Center Experience

Autor: Mindy Hsiao, George Yaghmour, Chris Foss, Anastasia Martynova

Publikováno v: Biology of Blood and Marrow Transplantation. 26:S289

Background Haploidentical hematopoietic cell transplantation (haplo-HCT) is a popular alternative to traditional HLA-matched HCT. The dose of CD34+ cells used during haplo-HCT to ensure favorable outcomes using PTCy has not yet been reported though 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::45ef6a8b26ff976656e16bd7311b3221
https://doi.org/10.1016/j.bbmt.2019.12.562

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání